Archives of Gynecology and Obstetrics

, Volume 291, Issue 6, pp 1277–1281 | Cite as

The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: a randomized clinical trial

  • Marjan Ahmad Shirvani
  • Narges Motahari-TabariEmail author
  • Abbas Alipour
General Gynecology



The aim of the study was to compare the effect of mefenamic acid and ginger on pain management in primary dysmenorrhea.


One hundred and twenty-two female students with moderate to severe primary dysmenorrhea were randomly allocated to the ginger and mefenamic groups in a randomized clinical trial. The mefenamic group received 250 mg capsules every 8 h, and the ginger group received 250 mg capsules (zintoma) every 6 h from the onset of menstruation until pain relief lasted 2 cycles. The intensity of pain was assessed by the visual analog scale. Data were analyzed by descriptive statistics, t test, Chi-square, Fisher exact test and repeated measurement.


The pain intensity in the mefenamic and ginger group was 39.01 ± 17.77 and 43.49 ± 19.99, respectively, in the first month, and 33.75 ± 17.71 and 38.19 ± 20.47, respectively, in the second month (p > 0.05). The severity of dysmenorrhea, pain duration, cycle duration and bleeding volume was not significantly different between groups during the study. The menstrual days were more in the ginger group in the first (p = 0.01) and second cycle (p = 0.04). Repeated measurement showed a significant difference in pain intensity within the groups by time, but not between groups.


Ginger is as effective as mefenamic acid on pain relief in primary dysmenorrhea. Ginger does not have adverse effects and is an alternative treatment for primary dysmenorrhea.


Ginger Mefenamic acid Pain relief Primary dysmenorrhea 



We thank the vice-chancellor for research of Mazandaran University of Medical Sciences for support this study. Our special thanks to students who participated in this study.

Conflict of interest

The authors have no conflicts of interest to disclose.

Ethical standard

This research has been approved by Ethics Committee of this deputy, conformity with Declaration of Helsinki.

Informed consent

All persons gave their informed consent prior to their inclusion in the study.


  1. 1.
    Abbaspour Z, Rostami M, Najjar S (2006) The effect of exercise on primary dysmenorrhea. J Res Health Sci 6(1):26–31Google Scholar
  2. 2.
    Brown J, Brown S (2010) Exercise for dysmenorrhoea. Cochrane Database Syst Rev 2. doi: 10.1002/14651858.CD004142
  3. 3.
    Cakir M, Mungan I, Karakas T, Girisken I, Okten A (2007) Menstrual pattern and common menstrual disorders among university students in Turkey. Pediatr Int 49(6):938–942CrossRefPubMedGoogle Scholar
  4. 4.
    Lefebvre G, Pinsonneault O, Antao V, Black A, Burnett M, Feldman K et al (2005) Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can 27(12):1117–1146PubMedGoogle Scholar
  5. 5.
    Dawood MY (2006) Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol 108(2):428–441CrossRefPubMedGoogle Scholar
  6. 6.
    French L (2005) Dysmenorrhea. Am Fam physician 71(2):285–291PubMedGoogle Scholar
  7. 7.
    Pistofidis G, Koukoura DG, Bardis NS, Filippidis M (2010) Laparoscopic treatment of a case of cystic adenomyosis of the lower uterine wall. J Minim Invasive Gynecol 17(6):S97CrossRefGoogle Scholar
  8. 8.
    Anaf V, Simon P, Nakadi EI, Fayt I, Buxant F, Simonart T et al (2000) Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod 15(8):1744–1750CrossRefPubMedGoogle Scholar
  9. 9.
    Abdul-Razzak KK, Ayoub NM, Abu-Taleb AA, Obeidat BA (2010) Influence of dietary intake of dairy products on dysmenorrhea. J Obstet Gynaecol Res 36(2):377–383CrossRefPubMedGoogle Scholar
  10. 10.
    Reddish S (2006) Dysmenorrhoea. Aust Fam Physician 35(11):842–844, 846–849Google Scholar
  11. 11.
    Cheng HF, Lin YH (2011) Selection and efficacy of self-management strategies for dysmenorrhea in young Taiwanese women. J Clin Nurs 20(7–8):1018–1025CrossRefPubMedGoogle Scholar
  12. 12.
    Marjoribanks J, Proctor ML, Farquhar C, Derks RS (2010) Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 20(1):CD001751. doi:  10.1002/14651858
  13. 13.
    Bolton PJ, Del Mar C, O’Connor V, Dean LM, Jarrett MS (2012) Exercise for primary dysmenorrhoea. Cochrane Libr. doi: 10.1002/14651858 Google Scholar
  14. 14.
    Proctor M, Farquhar C (2006) Diagnosis and management of dysmenorrhea. BMJ 332(7550):1134–1138CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Campbell MA, McGrath PG (1997) Use of medication by adolescents for the management of menstrual discomfort. Arch Pediatr Adolesc Med 151(9):905–913CrossRefPubMedGoogle Scholar
  16. 16.
    Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M et al (2009) Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol 44(9):879–888CrossRefPubMedGoogle Scholar
  17. 17.
    Traversa G, Walker AM, Ippolito FM, Caffari B, Capurso L, Dezi A et al (1995) Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology 6(1):49–54CrossRefPubMedGoogle Scholar
  18. 18.
    Zhu, X, Proctor M, Bensoussan A, Wu E, Smith CA (2008) Chinese herbal medicine for primary dysmenorrhoea. Cochrane Database Syst Rev 16(2):CD005288. doi: 10.1002/14651858
  19. 19.
    Proctor M, Murphy PA (2001) Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2:CD002124. doi:  10.1002/14651858
  20. 20.
    Rahnama P, Montazeri A, Huseini HF, Kianbakht S, Naseri M (2012) Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial. BMC Complement Altern Med 12(1):92. doi: 10.1186/1472-6882-12-92 CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Terry R, Posadzki P, Watson LK, Ernst E (2011) The use of ginger (Zingiber officinale) for the treatment of pain: a systematic review of clinical trials. Pain Med 12(12):1808–1818CrossRefPubMedGoogle Scholar
  22. 22.
    Jenabi E (2013) The effect of ginger for relieving of primary dysmenorrhoea. J Pak Med Assoc 63(1):8–10PubMedGoogle Scholar
  23. 23.
    Ozgoli G, Goli M, Moattar F (2009) Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. J Altern Complement Med 15(2):129–132CrossRefPubMedGoogle Scholar
  24. 24.
    Shahr-jerdy S, Hosseini RS, Gh ME (2012) Effects of stretching exercises on primary dysmenorrhea in adolescent girls. Biomed Human Kinet 4:127–132Google Scholar
  25. 25.
    Altman R, Marcussen K (2001) Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 44(11):2531–2538CrossRefPubMedGoogle Scholar
  26. 26.
    Mills S, Bone K (2000) Principles and practice of phytotherapy: modern herbal medicine. Churchill Livingstone, EdinburghGoogle Scholar
  27. 27.
    Kashefi F, Khajehei M, Cher MT, Alavian M, Asili J (2014) Comparison of the effect of ginger and zinc sulfate on primary dysmenorrhea: a placebo-controlled randomized trial. Pain Manag Nurs. doi: 10.1016/j.pmn.2013.09.001 PubMedGoogle Scholar
  28. 28.
    Halder A (2011) Effect of progressive muscle relaxation versus intake of ginger powder on dysmenorrhoea amongst the nursing students in Pune. Nurs J India 103(4):152–156Google Scholar
  29. 29.
    Chen CK, Huang YP, Fang HL, Huang YY (2013) Dysmenorrhea: a study of affected factors and approaches to relief among female students at a college in southern Taiwan. Hu li Za Zhi 60(3):40–50PubMedGoogle Scholar
  30. 30.
    Backon J (1991) Mechanism of analgesic effect of clonidine in the treatment of dysmenorrhea. Med Hypotheses 36(3):223–224CrossRefPubMedGoogle Scholar
  31. 31.
    Kim JK, Kim Y, Na KM, Surh YJ, Kim TY (2007) Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo. Free Radic Res 41(5):603–614CrossRefPubMedGoogle Scholar
  32. 32.
    Bieglmayer C, Hofer G, Kainz C, Reinthaller A, Kopp B, Janisch H (1995) Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecol Endocrinol 9(4):307–312CrossRefPubMedGoogle Scholar
  33. 33.
    Grzanna R, Lindmark L, Frondoza CG (2005) Ginger-an herbal medicinal product with broad anti-inflammatory actions. J Med Food 8(2):125–132CrossRefPubMedGoogle Scholar
  34. 34.
    Ife J, Magowan B (2004) Clinical obstetrics and gynecology. WB Saunders, EdinburghGoogle Scholar
  35. 35.
    Kikuzaki H, Nakatani N (1996) Cyclic diarylheptanoids from rhizomes of Zingiber officinale. Phytochemistry 43(1):273–277CrossRefGoogle Scholar
  36. 36.
    Schulick P (1996) Ginger: common spice and wonder drug. Herb Free Press, BrattleboroGoogle Scholar
  37. 37.
    Ali BH, Blunden G, Tanira MO, Nemmar A (2008) Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 46(2):409–420CrossRefPubMedGoogle Scholar
  38. 38.
    Kim SO, Kundu JK, Shin YK, Park JH, Cho MH, Kim TY et al (2005) Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-κB in phorbol ester-stimulated mouse skin. Oncogene 24(15):2558–2567CrossRefPubMedGoogle Scholar
  39. 39.
    Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sandawa U (1992) Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull 40:187–191Google Scholar
  40. 40.
    Yang JJ, Sun LH, She YF, Ge JJ, Li XH, Zhang RJ (2008) Influence of ginger-partitioned moxibustion on serum no and plasma endothelin-1 contents in patients with primary dysmenorrhea of cold-damp stagnation type. Zhen Ci Yan Jiu 33(6):409–412PubMedGoogle Scholar
  41. 41.
    Nievergelt A, Marazzi J, Schoop R, Altman KH, Gertsch J (2011) Ginger phenylpropanoids inhibit IL-1β and prostanoid secretion and disrupt arachidonate-phospholipid remodeling by targeting phospholipases A2. J Immunol 187(8):4140–4150CrossRefPubMedGoogle Scholar
  42. 42.
    Blumenthal M, Busse WR, Goldberg A (1998) The complete german commission e monographs: therapeutic guide to herbal medicines. Integrative Medicine, BostonGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Marjan Ahmad Shirvani
    • 1
  • Narges Motahari-Tabari
    • 1
    Email author
  • Abbas Alipour
    • 2
  1. 1.Department of MidwiferyMazandaran University of Medical Sciences, School of Nursing and MidwiferySariIran
  2. 2.Department of Community MedicineMazandaran University of Medical Sciences, School of MedicineSariIran

Personalised recommendations